Imageable Biomarkers for Radiotherapy Response

Area of Science:

• Oncology
• Radiotherapy
• Medical Imaging

Background:

• Optimizing radiation therapy requires balancing tumoricidal effects with toxicity.
• Radiotherapy resistance, driven by factors like tumor hypoxia and proliferation, necessitates personalized treatment strategies.
• Current approaches to overcome resistance may lead to unacceptable side effects in some patients.

Purpose of the Study:

• To explore the potential of imageable biomarkers for tailoring radiation therapy.
• To discuss biomarkers that can identify tumor hypoxia and proliferation.
• To enable upfront patient selection for optimized radiotherapy approaches.

Main Methods:

• Review of imageable biomarkers for hypoxia and proliferation.
• Discussion of biomarker mechanisms and imaging procedures.
• Analysis of quantification methods and clinical value.

Main Results:

• Imageable biomarkers offer a pathway to personalized radiotherapy.
• Specific biomarkers can assess tumor hypoxia and proliferation.
• These biomarkers aid in selecting appropriate treatment intensification or combination strategies.

Conclusions:

• Imageable biomarkers are crucial for patient-tailored radiotherapy.
• Assessing hypoxia and proliferation upfront can guide treatment decisions.
• This personalized approach aims to improve outcomes and reduce side effects.